- BioNotebook: IPOs, pipeline progress amidst bubble talk
- GSK lays out Japan launch plans
- Bimagrumab 3rd Novartis drug to win FDA 'breakthrough' designation
- ASIA BEAT: Affordability key as China JVs rebound
COMMENT Other Informa Comment
- Leadership lesson: How to slim down and shape up, Kress style
- UCB's Lode Dewulf: 'We can and should talk to patients'